CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
We need your help
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
A 42-year-old HIV patient with leukemia continues to show no signs of HIV in his blood, two years after a stem cell transplant from a donor with a gene mutation that confers natural resistance to the virus that causes AIDS.
The stunning findings were published Wednesday in The New England Journal of Medicine, according to CNN, but doctors caution that the stem cell treatment is too dangerous to be of routine use to most people infected with HIV.
In the study, reported CNN, "the team deliberately chose a compatible donor who has a naturally occurring gene mutation that confers resistance to HIV. The mutation cripples a receptor known as CCR5, which is normally found on the surface of T cells, the type of immune system cells attacked by HIV.
"The mutation is known as CCR5 delta32 and is found in 1 percent to 3 percent of white populations of European descent.
"HIV uses the CCR5 as a co-receptor (in addition to CD4 receptors) to latch on to and ultimately destroy immune system cells. Since the virus can't gain a foothold on cells that lack CCR5, people who have the mutation have natural protection. (There are other, less common HIV strains that use different co-receptors.)
"People who inherit one copy of CCR5 delta32 take longer to get sick or develop AIDS if infected with HIV. People with two copies (one from each parent) may not become infected at all. The stem cell donor had two copies."
Doctors say that while the risky stem cell transplant option should not be routinely exercised, the findings point the way toward development of potentially safer CCR5-disabling gene therapies or treatments that can be injected into the body.
From our Sponsors
Most Popular
Bizarre Epstein files reference to Trump, Putin, and oral sex with ‘Bubba’ draws scrutiny in Congress
November 14 2025 4:08 PM
True
Jeffrey Epstein’s brother says the ‘Bubba’ mentioned in Trump oral sex email is not Bill Clinton
November 16 2025 9:15 AM
True
Watch Now: Pride Today
Latest Stories
Is 'Heated Rivalry' based on a true story? Yes...sort of
December 08 2025 5:01 PM
FBI agents fired for kneeling at George Floyd protest sue Kash Patel and other officials
December 08 2025 4:46 PM
Colin Allred targets first LGBTQ+ congresswoman from Texas for House seat as Jasmine Crockett runs for Senate
December 08 2025 4:00 PM
True
There are no out NHL players. Could 'Heated Rivalry' change that?
December 08 2025 3:26 PM
World Cup LGBTQ+ Pride Match will feature two countries where being gay is illegal
December 08 2025 1:33 PM
Marjorie Taylor Greene says Trump was 'extremely angry' over vote to release Epstein files
December 08 2025 11:58 AM
Cynthia Erivo makes Golden Globes history with second nomination
December 08 2025 11:48 AM
Another University of Oklahoma instructor suspended in biblical psychology paper grading controversy
December 08 2025 10:01 AM
The next out member of Congress may be a gay man from Utah
December 08 2025 7:00 AM
Opinion: When museums go silent, erasure speaks louder
December 08 2025 6:00 AM




































































Charlie Kirk DID say stoning gay people was the 'perfect law' — and these other heinous quotes